Baxter International INC Form 4 insider transactions

Anita A. Zielinski, SVP, Interim CFO, CAO & Cntrlr at Baxter International Inc., received a special grant of restricted stock units.

Steven P. Wallace, President of Advanced Surgery at Baxter International Inc., reported a transaction involving the forfeiture of shares to cover tax withholding.

Baxter International Inc. director David S. Wilkes received a grant of 12,836 fully vested shares of common stock.

Baxter International Inc. director Amy McBride Wendell received a grant of 12,836 fully vested shares of common stock on May 5, 2026.

Baxter International Inc. Director Patricia Morrison acquired 12,836 shares of common stock on May 5, 2026, as part of a grant.

Baxter International Inc. director Jeffrey A. Craig received a grant of 12,836 fully vested shares of common stock.

Baxter International Inc. director William A. Ampofo II acquired 12,836 shares of common stock through a grant.

Baxter International's President and CEO, Andrew P. Hider, was granted 201,804 restricted stock units and 488,506 stock options as part of his compensation.

Cynthia Carlisle, Baxter International's EVP and CHRO, was granted 29,677 restricted stock units and 43,103 stock options as part of her compensation.

Baxter International EVP Reazur Rasul forfeited 1,614 shares of common stock to cover tax obligations related to vested restricted stock units.

Baxter International's Group President, Maria Cecilia Soriano, received new grants of restricted stock units and stock options, alongside a disposition of shares for tax withholding.

Baxter International's EVP and General Counsel, David S. Rosenbloom, received new equity grants and reported shares withheld for tax obligations.

Baxter International's EVP and CFO, Joel T. Grade, was granted 42,735 restricted stock units and 103,448 stock options as part of the company's 2021 Incentive Plan.

Baxter International's SVP, CAO, and Controller, Anita A. Zielinski, was granted 30,864 restricted stock units.

Baxter International Group President Maria Cecilia Soriano reported the vesting of performance share units and subsequent share disposition for tax purposes.

Baxter International's EVP and General Counsel, David S. Rosenbloom, reported the vesting of performance share units and subsequent tax-related share forfeiture.

Baxter International's EVP, Group President, Healthcare, Reazur Rasul, saw performance share units vest, resulting in a net increase in his beneficial ownership after tax withholding.

Baxter International's EVP and CFO, Joel T. Grade, reported the vesting of performance share units and subsequent tax-related share forfeiture.

Baxter International Inc. EVP and Chief HR Officer Jeanne K. Mason disposed of 650 shares of common stock to cover tax obligations related to restricted stock unit awards.

Baxter International's EVP and CFO, Joel T. Grade, reported a disposition of 8,288 common shares to cover tax withholdings from vested restricted stock units.

Baxter International EVP Alok Sonig disposed of 3,191 shares of common stock to cover tax obligations related to vested restricted stock units.

Baxter International's President and CEO, Andrew Hider, was granted substantial equity awards, including restricted stock units and stock options, effective September 2, 2025.

Baxter International's EVP and CFO, Joel T. Grade, was granted 102,712 restricted stock units, vesting in September 2028.

Baxter International's EVP, Chief Supply Chain Officer, James W. Borzi, disposed of 1,848 shares of common stock to cover tax obligations related to vested restricted stock units.

Baxter International's Chair of the Board, David Brent Shafer, disposed of 31,337 shares of common stock to cover tax obligations related to vested restricted stock units.

David S. Rosenbloom, EVP and General Counsel of Baxter International Inc., reported the disposition of 16,548 shares of common stock to cover tax withholding related to vested restricted stock units.

Director David S. Wilkes reports acquisition and disposal of Baxter International Inc. common stock.

Director Amy McBride Wendell reported the acquisition of Baxter International Inc. common stock through a grant and dividend reinvestment, and the disposal of shares.

Director Cathy R. Smith reports acquisition and disposal of Baxter International Inc. common stock.

Director Nancy M. Schlichting reports acquiring 7,183 shares of Baxter International common stock on May 6, 2025.